Trial intelligence / Profile preview

Phase II randomized study of capecitabine + bevacizumab versus capecitabine + oxaliplatin as neoadjuvant therapy in resectable locally advanced rectal cancer

2009-010192-24Phase 2Completed

Sponsor

Spanish Cooperative Group for Digestive Tumour Therapy

Start

Mar 2009

Modality

Monoclonal Antibodies → Antibody-Based Therapeutics, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1